Appropriate hemostasis by routine use of ultrasound echo-guided transfemoral access and vascular closure devices after lower extremity percutaneous revascularization
Tóm tắt
Từ khóa
Tài liệu tham khảo
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.
Organisation European Stroke, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851–906.
Ishihara T, Iida O, Awata M, Nanto K, Shiraki T, Okamoto S, et al. Extensive arterial repair 1 year after paclitaxel-coated nitinol drug-eluting stent vs. bare-metal stent implantation in the superficial femoral artery. Cardiovasc Interv Ther. 2015;30(1):51–6.
Kalish J, Eslami M, Gillespie D, Schermerhorn M, Rybin D, Doros G, et al. Routine use of ultrasound guidance in femoral arterial access for peripheral vascular intervention decreases groin hematoma rates. J Vasc Surg. 2015;61:1231–8.
Gedikoglu M, Oguzkurt L, Gur S, Andic C, Sariturk C, Ozkan U. Comparison of ultrasound guidance with the traditional palpation and fluoroscopy method for the common femoral artery puncture. Catheter Cardiovasc Interv. 2013;82(7):1187–92.
Gardiner GA Jr, Meyerovitz MF, Stokes KR, Clouse ME, Harrington DP, et al. Complications of transluminal angioplasty. Radiology. 1986;159:201–8.
Sanborn TA, Ebrahimi R, Manoukian SV, McLaurin BT, Cox DA, et al. Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Circ Cardiovasc Interv. 2010;3:57–62.
Biancari F, D’Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159:518–31.
Behan MW, Large JK, Patel NR, Lloyd GW, Sulke AN. A randomised controlled trial comparing the routine use of an Angio-Seal STS device strategy with conventional femoral haemostasis methods in a district general hospital. Int J Clin Pract. 2007;61:367–72.
Henry M, Amor M, Allaoui M, Tricoche O. A new access site management tool: the Angio-Seal hemostatic puncture closure device. J Endovasc Surg. 1995;2:289–96.
Holm NR, Sindberg B, Schou M, Maeng M, Kaltoft A, Bøttcher M, et al. Randomized comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study. Eurointervention. 2014;10:183–90.
Wong SC, Bachinsky W, Cambier P, Stoler R, Aji J, Rogers JH, et al. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure’s Vascular Closure Device Speeds Hemostasis Trial). JACC Cardiovasc Interv. 2009;2:785–93.
Nelson PR, Kracjer Z, Kansal N, Rao V, Bianchi C, Hashemi H, et al. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). J Vasc Surg. 2014;59:1181–93.
Rutherford RB, Becker GJ. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. J Vasc Interv Radiol. 1991;2:169–74.
Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;1(83):E212–20.
Tammam K, Ikari Y, Yoshimachi F, Saito F, Hassan W. Impact of transradial coronary intervention on bleeding complications in octogenarians. Cardiovasc Interv Ther. 2016 [Epub ahead of print].
Tarzamni MK, Eshraghi N, Fouladi RF, Afrasiabi A, Halimi M, Azarvan A. Atherosclerotic changes in common carotid artery, common femoral artery, and ascending aorta/aortic arch in candidates for coronary artery bypass graft surgery. Angiology. 2012;63:622–9.
Fargen KM, Hoh BL, Mocco J. A prospective randomized single-blind trial of patient comfort following vessel closure: extravascular synthetic sealant closure provides less pain than a self-tightening suture vascular compression device. J Neurointerv Surg. 2011;3:219–23.
Hermiller JB, Leimbach W, Gammon R, Karas SP, Whitbourn RJ, Wong SC, et al. A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients. J Invasive Cardiol. 2015;27:129–36.
Katzenschlager R, Tischler R, Kalchhauser G, Panny M, Hirschl M. Angio-Seal use in patients with peripheral arterial disease (ASPIRE). Angiology. 2009;60:536–8.
Chu G, Yang W, Zhang G, Zhang Z, Liu S, Sun B, et al. Safety and efficacy of the StarClose vascular closure system following 8-Fr sheath placement for intra-aortic balloon pump: a single-center analysis of 42 consecutive patients. Med Princ Pract. 2014;23:313–7.
Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc. 2005;80:1011–5.
Franco J, Motaganahalli R, Habeeb M, Wittgen C, Peterson G. Risk factors for infectious complications with angio-seal percutaneous vascular closure devices. Vascular. 2009;17:218–21.